United States Bioanalytical Testing Services Market 2025: Industry Developments, Future Growth, Share & Industry Insights | Eurofins Scientific, Lonza, Charles River Laboratories, Syneos Health, ICON plc, IQVIA

The Global Bioanalytical Testing Services Market size increased from US$ 3.80 billion in 2023 to US$ 4.20 billion in 2024 and is projected to reach US$ 10.81 billion by 2033, growing at a CAGR of 12.6% during the forecast period 2025-2033.

DataM Intelligence has published a new research report on "Bioanalytical Testing Services Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/bioanalytical-testing-services-market?sg

Key Players: SGS Société Générale de Surveillance SA, Eurofins Scientific, Lonza, Charles River Laboratories, Syneos Health, ICON plc, IQVIA, WuXi AppTec, Intertek Group Plc., Thermo Fisher Scientific Inc.

Key Development:

USA - Industry Latest News:

✅ 04-Feb-2025 - Ardena completed the acquisition of Catalent's Somerset (NJ) drug-product manufacturing facility and announced plans to add a new bioanalytical laboratory at the site to expand its North American bioanalytical capabilities.

✅ 28-Feb-2025 / 03-Mar-2025 - NAMSA completed its acquisition of WuXi AppTec's U.S. medical-device testing operations (facilities in Minnesota and Georgia), strengthening US lab/testing capacity and regulatory/testing services (impacts adjacent bioanalytical/med-tech testing capacity).

✅ 06-Aug-2025 - Normec (European TICC group) announced multiple U.S. acquisitions including NorthEast BioAnalytical Laboratories (Hamden, CT) - a CLIA/clinical bioanalytical lab - marking a Europe→US consolidation play that affects the US bioanalytical landscape.

Japan - Industry Latest News:

✅ 25-Jun-2025 - Sysmex received manufacturing & marketing approval in Japan for an assay kit that assesses risk of adverse reactions to anti-amyloid β antibody drugs (APOE genotype assay) - a domestically approved bioanalytical/diagnostic assay with clinical decision-support implications.

✅ Mar-2025 (Pittcon announcements) - Shimadzu unveiled new analytical instruments (including LC-MS developments announced around Pittcon 2025) and continued roll-outs of upgraded LC-MS platforms during 2025 - relevant for bioanalytical labs upgrading mass-spec capacity.

✅ Jul-2025 - Tigermed completed the acquisition of Japanese CRO Micron (imaging/biomarker CRO) - an example of regional CRO consolidation and capability expansion in Japan (impacts biomarker and bioanalytical service provision).

Korea (South Korea) - Industry Latest News:

✅ 05-Aug-2025 - EukairosCell (Korea) signed an MOU with Invitrocue, Genecast and Xylonix to launch Korea's first advanced IVD lab focused on real-time cancer diagnostics - a notable local move expanding IVD/bioanalytical diagnostics capacity in Korea.

✅ May-2025 - BIO KOREA 2025 (Seoul, May 7-9) showcased numerous innovations (AI, automation, biomarker tools) and catalysed partnerships and product demonstrations relevant to bioanalytical testing - an important regional industry event where new lab technologies and collaborations were highlighted.

✅ 2025 (ongoing) - Major Korean CDMO/CRO players (e.g., Samsung Biologics) continued expanding service portfolios and global deals through 2025 - while much of Samsung's activity is CDMO, the company's push to broader service coverage influences regional bioanalytical and supporting lab capacity.

Europe - Industry Latest News:

✅ 01-Apr-2025 / 31-Mar-2025 - Eurofins completed the acquisition and transfer of SYNLAB's clinical diagnostics operations in Spain (closing end-March/early-April 2025), expanding Eurofins' clinical-diagnostics and molecular testing footprint in Europe.

✅ 04-Feb-2025 - Ardena (Belgium) completed the Catalent Somerset acquisition (see USA entry) - part of a European CRO/CDMO expanding transatlantic operations and bioanalytical capabilities. (Europe→NA expansion example.)

✅ 06-Aug-2025 - Normec (Netherlands, TICC group) announced entry into the U.S. via three strategic acquisitions including a CLIA bioanalytical lab - reflects active European consolidation and cross-border expansion in testing and bioanalytical services.

Growth Forecast Projected:

The Global Bioanalytical Testing Services Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Bioanalytical Testing Services Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Buy Now & Unlock 360° Market Intelligence: https://www.datamintelligence.com/buy-now-page?report=bioanalytical-testing-services-market?sg

Key Segments:

By Test Type(Pharmacokinetic (PK) Testing, Pharmacodynamics (PD) Testing, ADME Testing, Bioavailability Testing, Bioequivalence Testing, Biomarker Testing, Cell-based Assay, Others)

By Molecule Type(Small Molecule, Large Molecule)

By End User(Biopharmaceutical Companies, Clinical Research Organizations, Contract Development and Manufacturing Organization (CDMO)

By Regions Covered(North America, Europe, Asia-Pacific, South America and the Middle East & Africa)

Regional Analysis for Market:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.

Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.

Chapter 3: Offers an in-depth look at the competitive landscape among Bioanalytical Testing Services producers, including revenue shares, strategic moves, and recent mergers and acquisitions.

Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.

Chapters 5 & 6: Analyze Bioanalytical Testing Services revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.

Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.

Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.

Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.

Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.

Get Customization in the report as per your requirements: https://datamintelligence.com/customize/bioanalytical-testing-services-market?sg

FAQ's

Q1: What is the current size of the Bioanalytical Testing Services Market?

A: The Bioanalytical Testing Services Market stood at US$ 4.20 billion in 2024 and is set to experience remarkable growth, reaching US$ 10.81 billion by 2033

Q2: How fast is the Bioanalytical Testing Services Market growing?

A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 12.6% from 2025-2033

Have any Enquiry of This Report @ https://www.datamintelligence.com/enquiry/bioanalytical-testing-services-market?sg

Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.

Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.